- Home
- CUPR vs DTIL Comparison
CUPR vs DTIL Comparison
Compare CUPR & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUPR
- DTIL
- Stock Information
- Founded
- CUPR 2019
- DTIL 2006
- Country
- CUPR Singapore
- DTIL United States
- Employees
- CUPR N/A
- DTIL N/A
- Industry
- CUPR
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CUPR
- DTIL Health Care
- Exchange
- CUPR NYSE
- DTIL Nasdaq
- Market Cap
- CUPR 43.2M
- DTIL 51.6M
- IPO Year
- CUPR 2025
- DTIL 2019
- Fundamental
- Price
- CUPR $7.30
- DTIL $4.49
- Analyst Decision
- CUPR
- DTIL Strong Buy
- Analyst Count
- CUPR 0
- DTIL 2
- Target Price
- CUPR N/A
- DTIL $47.00
- AVG Volume (30 Days)
- CUPR 300.3K
- DTIL 546.0K
- Earning Date
- CUPR 01-01-0001
- DTIL 07-31-2025
- Dividend Yield
- CUPR N/A
- DTIL N/A
- EPS Growth
- CUPR N/A
- DTIL N/A
- EPS
- CUPR N/A
- DTIL N/A
- Revenue
- CUPR $35,406.00
- DTIL $51,141,000.00
- Revenue This Year
- CUPR N/A
- DTIL N/A
- Revenue Next Year
- CUPR N/A
- DTIL $30.20
- P/E Ratio
- CUPR N/A
- DTIL N/A
- Revenue Growth
- CUPR N/A
- DTIL N/A
- 52 Week Low
- CUPR $3.51
- DTIL $3.61
- 52 Week High
- CUPR $7.46
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- CUPR N/A
- DTIL 54.93
- Support Level
- CUPR N/A
- DTIL $4.08
- Resistance Level
- CUPR N/A
- DTIL $4.38
- Average True Range (ATR)
- CUPR 0.00
- DTIL 0.28
- MACD
- CUPR 0.00
- DTIL 0.05
- Stochastic Oscillator
- CUPR 0.00
- DTIL 85.26
About CUPR CUPRINA HOLDINGS (CAYMAN) LIMITED
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.